Relapse of XXXX -induced @entity2275 and gastric mucosal @entity4770 level in @entity35 .

@entity1066 @entity4770 @entity35 @entity1543 @entity2275
The healing process of @entity1543 -induced @entity2275 in @entity35 was observed with an endoscope for 365 d after @entity1066 induction. The @entity1066 were induced by @entity1543 solutions of various concentrations (2.5 (I), 5.0 (II), 10 (III) and 20% (IV); 0.05 ml). On day 3, a positive correlation was observed between the @entity1066 index (UI) and the concentration of @entity1543 solution. On day 365, cumulative healing rates in groups I, II, III and IV amounted to 100, 100, 58.3 and 51.7%, respectively. The cumulative relapse rates in groups I, II, III and IV were 0, 13.6, 66.7 and 58.6%, respectively. Significant correlations were observed between initial UI values and cumulative healing or cumulative relapse rate. On day 365, @entity35 were divided into two groups, a healed group and non-healed group, and the gastric mucosal @entity4770 (PGI2) level was measured by bioassay. The @entity4770 level around @entity1066 in @entity1066 -induced @entity35 was higher than in normal @entity35 , and it was higher in non-healed @entity35 than in healed @entity35 . Moreover, the PGI2 level was higher in those groups which showed a higher cumulative relapse rates. The above results indicated that the initial @entity1066 size and the PGI2 level around the @entity1066 might correlate to @entity1066 or exacerbation.
